Literature DB >> 17570430

Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial.

Y Ehrlich1, O Yossepowitch, D Margel, D Lask, P M Livne, J Baniel.   

Abstract

PURPOSE: Lower urinary tract operations are being increasingly performed in elderly patients, in whom aspirin intake is common for preventing cardiovascular disease. We determined the safety of early aspirin re-initiation after lower urinary tract surgeries.
MATERIALS AND METHODS: A randomized, open label clinical trial was done. The study cohort included patients referred for transurethral prostatectomy, open prostatectomy and transurethral resection of bladder tumor while receiving aspirin prophylaxis. After controlling for surgical modality patients were randomized into 2 arms, including aspirin treatment initiation 24 hours after discontinuing of bladder irrigation (early treatment group) and aspirin treatment initiation 3 weeks after surgery (late treatment group). Primary end points were pre-discharge hematuria necessitating the restoration of bladder irrigation or the cessation of aspirin treatment and late hematuria treated in an urgent care setting, requiring hospital admission or compelling the cessation of aspirin treatment.
RESULTS: A total of 120 patients were enrolled, including 60 per treatment group. There were no significant differences between the groups in surgery related factors that could have affected postoperative bleeding. Primary end points were attained by 16 of the 120 patients (13.6%), including 10 of the 60 (16.7%) in the early treatment group and 6 (10%) in the late treatment group (p = 0.28). Time to catheter removal and persistent hematuria duration were similar in the 2 groups. Cardiovascular morbidity was noted in 3 of 120 patients, of whom all were assigned to the early treatment group.
CONCLUSIONS: Early aspirin initiation after lower urinary tract surgeries does not appear to carry an increased risk of postoperative bleeding. Thus, it may be considered in patients at high risk for cardiovascular morbidity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570430     DOI: 10.1016/j.juro.2007.03.134

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  [ASA and clopidogrel for urological operations. Perioperative management].

Authors:  C Fischer; G Lümmen
Journal:  Urologe A       Date:  2013-11       Impact factor: 0.639

2.  Impact of oral anticoagulation on morbidity of transurethral resection of the prostate.

Authors:  Aurélien Descazeaud; Gregoire Robert; Souhil Lebdai; Alain Bougault; Abdel Rahmene Azzousi; Olivier Haillot; Marian Devonec; Marc Fourmarier; Christian Saussine; Nicolas Barry-Delongchamps; Alexandre de la Taille
Journal:  World J Urol       Date:  2010-06-25       Impact factor: 4.226

3.  Risks and complications of transurethral resection of bladder tumor among patients taking antiplatelet agents for cardiovascular disease.

Authors:  Stefano Picozzi; Carlo Marenghi; Cristian Ricci; Giorgio Bozzini; Stefano Casellato; Luca Carmignani
Journal:  Surg Endosc       Date:  2013-09-04       Impact factor: 4.584

4.  [Superficial bladder cancer: Transurethral resection and instillation therapy].

Authors:  M Schenck; G Lümmen
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639

Review 5.  Prevention and management of TURP-related hemorrhage.

Authors:  Liam E Kavanagh; Gregory S Jack; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2011-08-16       Impact factor: 14.432

6.  Secondary hemorrhage after bipolar transurethral resection and vaporization of prostate.

Authors:  Chi-Hang Yee; Joseph Hon-Ming Wong; Peter Ka-Fung Chiu; Jeremy Yuen-Chun Teoh; Chi-Kwok Chan; Eddie Shu-Yin Chan; See-Ming Hou; Chi-Fai Ng
Journal:  Urol Ann       Date:  2016 Oct-Dec

7.  Antiplatelet therapy and bladder tumor resection.

Authors:  Apul Goel; Rohan Patel
Journal:  Transl Androl Urol       Date:  2018-05

8.  Antiplatelet drugs and the perioperative period: What every urologist needs to know.

Authors:  Pawan Vasudeva; Apul Goel; Vengetesh K Sengottayan; Satyanarayan Sankhwar; Divakar Dalela
Journal:  Indian J Urol       Date:  2009-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.